34 results
8-K
EX-99.1
YMAB
Y-Mabs Therapeutics Inc
14 Mar 24
Y-mAbs Therapeutics Announces Resignation of Chief Financial Officer
9:17am
the future of the Company’s business, including with respect to expansion and its goals; the Company’s plans and strategies, development
8-K
EX-99.1
YMAB
Y-Mabs Therapeutics Inc
4 Mar 24
Y-mAbs Appoints Oncology Executive Mary Tagliaferri, M.D. to its Board of Directors
6:05am
statements regarding the future of the Company’s business, including with respect to expansion and its goals; the Company’s plans and strategies
8-K
EX-99.1
YMAB
Y-Mabs Therapeutics Inc
29 Feb 24
Y-mAbs Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Developments
4:04pm
statements regarding the future of the Company’s business, including with respect to expansion and its goals; the Company’s plans and strategies
8-K
EX-99.1
4z4mnxh5l4g
9 Jan 24
Results of Operations and Financial Condition
6:45am
8-K
EX-99.1
sa6la0i0697ko xd0l
13 Nov 23
Y-mAbs Reports Third Quarter 2023 Financial Results and Recent Corporate Developments
4:47pm
8-K
x6apaho59v0ub0l
18 Oct 23
Y-mAbs Names Michael Rossi as President and Chief Executive Officer and Director
4:09pm
8-K
EX-99.1
bb0dg
10 Aug 23
Y-mAbs Reports Second Quarter 2023 Financial Results and Recent Corporate Developments
4:30pm